We handle every step of the prior authorization processfrom benefit verification to insurance company submissions and follow-ups
Found a good doc, dialed in your protocol, got your bloodwork looking clean
Pharmacotherapy Synergy: Metformin, GLP-1/GIP Agents, and Lisdexamfetamine Metformin : reduces hepatic gluconeogenesis, improves hepatic insulin sensitivity, modest weight loss, beneficial in PCOS and MASLD risk (Rubio et al., 2020) Tirzepatide (GIP/GLP-1) : significant satiety, delayed gastric emptying, improved insulin secretion in a glucose-dependent manner, glucagon reduction, weight loss, improved A1C/triglycerides/inflammation (Frias et al., 2021) Contraception considerations : incretin agents may delay gastric emptying
Programmable base editing of AT to GC in genomic DNA without DNA cleavage